Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity
Authors
Keywords
-
Journal
JOURNAL OF PSYCHOPHARMACOLOGY
Volume -, Issue -, Pages 026988112097839
Publisher
SAGE Publications
Online
2021-01-14
DOI
10.1177/0269881120978398
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
- (2020) Teodora Doherty et al. CNS DRUGS
- Effects of subcutaneous esketamine on blood pressure and heart rate in treatment-resistant depression
- (2020) Lorena Catarina Del Sant et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effects of ketamine in patients with treatment-refractory generalized anxiety and social anxiety disorders: Exploratory double-blind psychoactive-controlled replication study
- (2019) Paul Glue et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
- (2019) Simone B. Sartori et al. PHARMACOLOGY & THERAPEUTICS
- Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3
- (2019) Rachel Ochs-Ross et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study
- (2019) Fernanda S. Correia-Melo et al. JOURNAL OF AFFECTIVE DISORDERS
- Comorbidity with more anxiety disorders associated with a poorer prognosis persisting at the 10-year follow-up among patients with major depressive disorder
- (2019) Ching-I Hung et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2018) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- Standardisation framework for the Maudsley staging method for treatment resistance in depression
- (2018) Abebaw Fekadu et al. BMC Psychiatry
- Multiple-therapy-resistant major depressive disorder: a clinically important concept
- (2018) R. H. McAllister-Williams et al. BRITISH JOURNAL OF PSYCHIATRY
- Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders
- (2018) Paul Glue et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
- (2018) Carola Rong et al. International Journal of Environmental Research and Public Health
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectiveness
- (2018) Rejish K Thomas et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression
- (2018) Yanling Zhou et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study
- (2018) A. Kautzky et al. ACTA PSYCHIATRICA SCANDINAVICA
- Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion
- (2017) Steven J. Pennybaker et al. JOURNAL OF AFFECTIVE DISORDERS
- Ketamine for Depression, 3: Does Chirality Matter?
- (2017) Chittaranjan Andrade JOURNAL OF CLINICAL PSYCHIATRY
- Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency?
- (2017) Chittaranjan Andrade JOURNAL OF CLINICAL PSYCHIATRY
- Ketamine’s dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders
- (2017) Paul Glue et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial
- (2017) Jerome H Taylor et al. NEUROPSYCHOPHARMACOLOGY
- Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression
- (2016) C. K. Loo et al. ACTA PSYCHIATRICA SCANDINAVICA
- Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
- (2016) Jaskaran B. Singh et al. BIOLOGICAL PSYCHIATRY
- Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
- (2016) Ronald S Duman et al. NATURE MEDICINE
- The use of ketamine as an antidepressant: a systematic review and meta-analysis
- (2015) Caoimhe M. Coyle et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Ketamine*
- (2015) Rachel Quibell et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Ketamine for the Treatment of Depression in Patients Receiving Hospice Care: A Retrospective Medical Record Review of Thirty-One Cases
- (2015) Alana Iglewicz et al. PSYCHOSOMATICS
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2015) C Yang et al. Translational Psychiatry
- Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
- (2014) Mark J. Niciu et al. JOURNAL OF CLINICAL PSYCHIATRY
- Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial
- (2014) James W Murrough et al. NEUROPSYCHOPHARMACOLOGY
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
- (2012) James W. Murrough et al. BIOLOGICAL PSYCHIATRY
- Risk factors for chronic depression — A systematic review
- (2010) Lars Hölzel et al. JOURNAL OF AFFECTIVE DISORDERS
- A Multidimensional Tool to Quantify Treatment Resistance in Depression
- (2009) Abebaw Fekadu et al. JOURNAL OF CLINICAL PSYCHIATRY
- Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression: A STAR*D Report
- (2008) Maurizio Fava et al. AMERICAN JOURNAL OF PSYCHIATRY
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
- (2008) Paul A. Harris et al. JOURNAL OF BIOMEDICAL INFORMATICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More